CD BioGlyco is a prominent biotechnology company specializing in glycobiology research, offering a wide array of high-quality products and services tailored to enhance research outcomes. The company employs a combination of advanced technology platforms and experienced technicians to provide comprehensive services in glycomics, glycoproteomics, and glycoengineering. Their offerings include detailed analyses of carbohydrates, enzymes, glycoconjugates, and glycosylation-related products, as well as custom synthesis services. CD BioGlyco's commitment to innovation is evident in their ability to deliver precise data and solutions that streamline research processes for scientists globally.

In addition to their product offerings, CD BioGlyco provides specialized analytical services that encompass carbohydrate isolation, characterization, and high-throughput screening. Their expertise extends to the development of glycosylation inhibitors and the production of various glycan-related antigens, which are crucial for advancing therapeutic research. The company also focuses on the analysis of complex carbohydrates from diverse sources, including plants, microbes, and human milk, thereby supporting a wide range of applications in both academic and industrial settings. Through their extensive capabilities, CD BioGlyco aims to facilitate significant advancements in glycobiology and related fields.

United States

CD BioGlyco provides various carbohydrates, glycoconjugates, enzymes and related products, as well as many glycobiology related research services.

CD BioGlyco

Company Details